Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment
Clinical and Experimental Immunology - United Kingdom
doi 10.1111/cei.13255
Full Text
Open PDFAbstract
Available in full text
Date
January 21, 2019
Authors
Publisher
Wiley